HQTC(SH:688151)2022-10-27 16:00Financial Performance - The company's operating revenue for Q3 2022 was ¥106,011,464.48, a decrease of 73.15% compared to the same period last year[5] - Net profit attributable to shareholders was ¥3,749,603.22, down 96.82% year-on-year[5] - Total operating revenue for Q3 2022 was ¥449,130,915.19, a decrease of 55.6% compared to ¥1,011,001,295.80 in the same period of 2021[34] - Net profit for Q3 2022 was ¥99,449,397.88, a decline of 67.8% compared to ¥308,956,966.44 in Q3 2021[36] - Basic earnings per share for Q3 2022 were ¥0.29, down from ¥1.20 in the same quarter of 2021[39] Cash Flow - The cash flow from operating activities showed a net outflow of ¥35,826,635.82, a decrease of 65.63% compared to the previous year[5] - Operating cash flow net amount was -$166.13 million, a decrease from -$43.16 million year-over-year[43] - Total cash inflow from operating activities was $407.12 million, down from $811.65 million year-over-year[43] - Cash outflow from operating activities totaled $573.25 million, compared to $854.82 million in the previous year[43] - The ending cash and cash equivalents balance was $3.32 billion, down from $476.13 million at the beginning of the period[44] Research and Development - Research and development expenses totaled ¥13,553,094.74, representing 12.78% of operating revenue, an increase of 9.06 percentage points year-on-year[7] - The company increased its R&D investment by 35.04% year-on-year, actively engaging in research activities[15] - Research and development expenses for Q3 2022 were ¥48,255,016.85, an increase of 35.0% compared to ¥35,734,029.80 in Q3 2021[34] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,122,829,349.15, a decrease of 3.20% from the end of the previous year[7] - The company's current assets totaled approximately ¥4.33 billion, down from ¥4.50 billion, indicating a decrease of around 3.7%[28] - Total liabilities as of the end of the reporting period were ¥903,218,971.83, down 14.7% from ¥1,058,217,018.85 at the end of the previous period[34] - The company's short-term liabilities included accounts payable of approximately ¥357.24 million, up from ¥328.45 million, an increase of about 8.8%[28] - The company’s non-current assets totaled approximately ¥791.07 million, slightly down from ¥793.62 million, a decrease of about 0.3%[28] Operational Challenges - The company experienced a significant decline in operating income due to delayed deliveries of special protective equipment orders and a slowdown in revenue contribution from vaccine rubber plugs[15] - Total operating costs for Q3 2022 were ¥409,534,735.71, down 38.4% from ¥665,281,924.21 year-over-year[34] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 23,629[17] - Total equity attributable to shareholders was ¥4,219,610,377.32, a slight decrease from ¥4,233,697,874.52 in the previous period[34] Financial Expenses - Financial expenses for Q3 2022 were -¥44,193,280.28, compared to -¥11,159,358.76 in Q3 2021, indicating a significant increase in financial costs[34]